Solosuyab
reacted to
In March, China's core CPI fell by 0.6% month-on-month, which is the lowest level for the same period since the data available in 2013.
$Hang Seng H-Share Index ETF.HK$ $Hang Seng Index.HK$ $.HXC.US$ $PDD.US$ $BABA.US$ $BABA-SW.HK$ $MEITUAN-W.HK$ $JD-SW.HK$ $JD.US$ $CHIQ.US$
$Hang Seng H-Share Index ETF.HK$ $Hang Seng Index.HK$ $.HXC.US$ $PDD.US$ $BABA.US$ $BABA-SW.HK$ $MEITUAN-W.HK$ $JD-SW.HK$ $JD.US$ $CHIQ.US$
![Picture](https://sgsnsimg.moomoo.com/sns_client_feed/103055095/20240411/13a17539c9ad436abf11a3af0483acd2.png/thumb?area=101&is_public=true)
6
Solosuyab
reacted to
Solosuyab
liked
UBTECH Robotics, The first humanoid robot stock in the Hong Kong stock market surged by around 50%, marking its largest single-day rise since its listing.
According to the Hang Seng Index quarterly review results, UBTECH was included in the Hang Seng Composite Index and the Hang Seng Shenzhen-Hong Kong Greater Bay Area Composite Index on March 4. It has also been officially added to the list of eligible securities in the Stock Connect.
$UBTECH ROBOTICS.HK$
According to the Hang Seng Index quarterly review results, UBTECH was included in the Hang Seng Composite Index and the Hang Seng Shenzhen-Hong Kong Greater Bay Area Composite Index on March 4. It has also been officially added to the list of eligible securities in the Stock Connect.
$UBTECH ROBOTICS.HK$
![This stock rose 50% yesterday](https://sgsnsimg.moomoo.com/sns_client_feed/103055095/20240307/26c68515dd9842dabc6294926c8003e1.png/thumb?area=101&is_public=true)
3
Solosuyab
voted
$LLY.US$ stock jumped in early November after the Food and Drug Administration signed off on its new weight-loss drug, a rival to $NVO.US$
Recently, Novo said a weekly shot of Ozempic helped stave off renal impairment and reduced the risk of death due to kidney or cardiovascular disease in patients with type 2 diabetes and chronic kidney disease. Earlier this year, Novo said patients who took Wegov...
Recently, Novo said a weekly shot of Ozempic helped stave off renal impairment and reduced the risk of death due to kidney or cardiovascular disease in patients with type 2 diabetes and chronic kidney disease. Earlier this year, Novo said patients who took Wegov...
5
Solosuyab
liked
$ENPH.US$ cut Q4 revenue guidance by 50%, I’m surprised it’s only down 17% after hours. It’s already down 42% in the past few months otherwise it would be down 40% tonight. I assume all solar stocks will get crushed tomorrow, some of them might be worth a buy soon but still too early. Need to see more flushing.
![Picture](https://ussnsimg.moomoo.com/feed_image/70865938/d54595e8aa1a39d2a8a50676d1ddc1cd.jpg/thumb)
3
Solosuyab
voted